COMPANY PROFILE

ProterixBio

Explore full profile

Developing innovative products to transform the management of chronic diseases

Billerica, United StatesFounded 2002Biotech & Life Sciences

Valuation $100–250M Last recorded · 2010

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

At a glance

Status: Closed
Founded: 2002
Headquarters: Billerica, United States
Employees: 16
Open positions: None listed
Dealroom signal: 0.0/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Testing, Biotechnology, Drug Development, Chronic Disease, Biotech and Pharma, Techbio, Hard Tech, medical testing, DT and LS, science-based
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

7 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
GROWTH EQUITY VCOther financing	Jul 2013	$19M	—	Undisclosed	—
DEBTDebt	Mar 2013	$1.1M	—	Undisclosed	—

Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

ProterixBio website traffic

Latest recorded traffic for ProterixBio is 240 monthly website visits, down 89.6% over the last three months. ProterixBio's team grew 0% over the past year.

Latest monthly visits240 3-month web change-89.6% 1-year team growth0%

Monthly website visitsOct 2017–Mar 2024

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
NGNostos GenomicsPartners with genetic labs to transform data into insights and deliver faster, clearer diagnoses for genetic diseases	Berlin, Germany	Acquired	13	$5.5M	$22M
BLBiorna Quantics LimitedCreating an intelligent solution for the future of preventative health and human optimisation	Southern District, Hong Kong	Closed
EHEdifice HealthOffers inflammatory health monitoring tests to help manage chronic inflammation and improve overall health and longevity	San Mateo, United States	Operational
SMScipher MedicineBringing precision medicine to complex diseases through the power of network medicine	Waltham, United States	Operational
LBLandos BiopharmaA clinical stage biopharmaceutical company focused on the development of first-in-class therapeutics for patients with autoimmune disease	Ashtabula, United States	Acquired
BPBiosortia PharmaceuticalsBiosortia is working on new drugs from deep access to the chemistry of the microbiome for immuno-oncology & immunological therapeutics	Dublin, United States	Operational
FLFrontage LaboratoriesPharmaceutical contract research organization	Upper Merion Township, United States	Acquired
AIAIBioTechContract research organization providing r&d and clinical testing services to institutions and government agencies	Richmond, United States	Closed